Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
96.56
-2.40 (-2.43%)
At close: Oct 30, 2026, 4:00 PM EDT
96.45
-0.11 (-0.11%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $9.02 billion as of October 30, 2026. It is the 2,287th most valuable company in the world and the 816th biggest in the United States. Its market cap has increased by 526.91% in one year.
Market Cap
9.02B
Enterprise Value
7.88B
1-Year Change
526.91%
Global Rank
Country Rank
#816 United States
Category
ChartMarket Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $9.02B, an increase of 7,978.54%. That is a compound annual growth rate of 51.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 8.55B | 236.27% |
| Dec 31, 2025 | 2.54B | 112.30% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Madrigal Pharmaceuticals | 9.94B |
| Krystal Biotech | 9.84B |
| Vaxcyte | 9.76B |
| Caris Life Sciences | 9.70B |
| Twist Bioscience | 9.58B |
| Protagonist Therapeutics | 9.37B |
| ImmunityBio | 8.79B |
| Corcept Therapeutics | 8.77B |